FDA Committee Unanimous on Two Gene Therapies

Summary by Ground News

The FDA's Cellular, Tissue, and Gene Therapies advisory committee met June 9-10 to consider the two products. The votes each day were unanimously in favor of the products. If approved, beti-cel will be the first potentially curative gene therapy for transfusion-dependent beta-thalassemia.

2 months ago

News Articles

More Filters

All

Left

Center

Right

Medscape

FDA Committee Unanimous on Two Gene Therapies

An FDA advisory committee gave a unanimous thumbs up to two new gene therapies, one for beta-thalassemia and the other for a rare but fatal neurologic disorder.

2 months ago·United States

Read Full Article